Hemlibra 30 mg/1 mL. 60 mg/0.4 mL. 105 mg/0.7 mL. 150 mg/1 mL Solution for injection

Indication

Routine prophylaxis to prevent bleeding in haemophilia A patients.

Dosage (summary)

Loading dose: 3 mg/kg weekly for 4 weeks; Maintenance: 1.5 mg/kg weekly, 3 mg/kg biweekly, or 6 mg/kg every four weeks.

Special Populations

• Paediatric patients
• Elderly patients
• Renal impairment
• Hepatic impairment

Pregnancy & Breastfeeding

Not recommended during pregnancy or breastfeeding.

Key Drug Interactions

• Activated prothrombin complex concentrate (aPCC)
• Recombinant factor VIIa (rFVIIa)

Contraindications

• Hypersensitivity to emicizumab or excipients

Common side effects

• Injection site reactions
• Headache
• Pyrexia
• Arthralgia
• Myalgia

Counselling Points

• Monitor for signs of thrombotic events
• Do not use aPCC unless necessary
• Proper injection technique is crucial